Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers - Related Studies

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers

This study has been completed.

Study NCT00002752. Last updated on November 22, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Central Nervous System Neoplasms
		Nervous System Neoplasms

2	More general conditions related to this trial
		Neoplasms
		Neoplasms by Site
		Nervous System Diseases

3	Additional drug interventions recognized in this trial
		Antibodies
		Antibodies, Monoclonal

4	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

5	Sponsors listed in this trial
		Duke University